Tobacco

22nd Century

22nd Century released FY2025 Q3 earnings on November 4 Pre-Market EST, actual revenue USD 4.011M, actual EPS USD 1.5499

22nd Century released FY2025 9 Months earnings on November 4, Pre-Market EST, actual revenue USD 6.001 M, actual EPS USD -68.9006

22nd Century FY2025 Q3 Earnings Release on November 4, 2025 Pre-Market EST

22nd Century released FY2025 Q2 earnings on August 14 Pre-Market EST, actual revenue USD 2.228 M, actual EPS USD -13.6079

22nd Century released FY2025 Semi-Annual Earnings on August 14 Pre-Market EST, actual revenue USD 4.503 M, actual EPS USD -47.3801

22nd Century to Release FY2025 Q2 Earnings Report on August 14, Pre-Market EST

22nd Century Group Collaborates with Tobacco Brands to Promote Low Nicotine Cigarettes

22nd Century Group Announces Progress in VLN® MRTP Renewal

22nd Century Group Reaches Expansion Agreement with Convenience Store Chain

22 Century Group Reports 48% Q1 2025 Revenue Growth

22nd Century released FY2025 Q1 earnings on May 13 Pre-Market (EST), actual revenue USD 2.275 M, actual EPS USD -56.8426

22 Century Group Reports Projected Quarterly Loss of 87 Cents Per Share

22nd Century to Release FY2025 Q1 Earnings Report on May 13, Pre-Market EST

22nd Century released FY2024 Q4 earnings on March 20 Pre-Market EST, actual revenue USD 4.021 M (forecast USD 8.907 M), actual EPS USD -410.2622 (forecast USD -14.9 K)

22nd Century released FY2024 earnings on March 20 Pre-Market (EST), actual revenue USD 24.38 M (forecast USD 33.53 M), actual EPS USD 0 (forecast USD -61.6 K)

22nd Century to release FY2024 Q4 earnings on March 20, Pre-Market EST; forecasted revenue 8.907 M USD, EPS -648.0006 USD

22nd Century Group Undergoes Major Restructuring Under New Management, Aiming for EBITDA Breakeven by Q4 2025

22nd Century released FY2024 9 Months earnings on November 12 Pre-Market (EST), actual revenue USD 10.04 M, actual EPS USD 0

22nd Century released FY2024 Q3 earnings on November 12 Pre-Market EST, actual revenue USD 2.514 M (forecast USD 8.557 M), actual EPS USD 0 (forecast USD -14.9 K)

22nd Century to Release FY2024 Q3 Earnings on November 12, Pre-Market EST; Forecasted Revenue: 8.557 M USD, EPS: -648.0006 USD

Mega Fortune

Processa Pharmaceuticals

cbdMD

Agape ATP

VYNE Therapeutics

Andersen

Inspirato

Medline Inc.

Creative Global Tech

GCI LIBERTY INC COM USD0.01 SER C SUBS RTS 17/12/2025

霧芯科技

Turning Point Brands

菲利普莫里斯

英美煙草

帝國煙草(ADR)

環球煙草

22世紀集團

奧馳亞集團

Ispire Tech

1606 Corp.

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap